LAUREN ZOGLEMAN: Open Payments
NPI 1396262770 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 62 payments from 16 companies in 2025. Trend: 2023 $1,055 · 2024 $577 · 2025 $1,191
Food & beverage: $1,101Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $363 |
| ABBVIE INC. | 15 | $256 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $124 |
| Lilly USA, LLC | 4 | $92 |
| PFIZER INC. | 4 | $61 |
| GENZYME CORPORATION | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Celltrion USA Inc. | 2 | $42 |
| Intercept Pharmaceuticals, Inc. | 2 | $30 |
| Ipsen Biopharmaceuticals, Inc | 2 | $28 |
Products named: TREMFYA, ENTYVIO, RINVOQ, OMVOH, SKYRIZI, DUPIXENT, ZENPEP, VEGZELMA.
Industry payments across KS — which companies pay providers there.
